THIS PRESENTATION IS VERY

CONTROVERSIAL

AND MAY BE OFFENSIVE TO SOME AUDIENCES

VIEWER DISCRETION IS ADVICED




Citations:

  • Kamceva, Marjia and others, "Role of Striatal-Enriched Tyrosine Phosphatase in Neuronal Function", in Neural Plasticity, 2016: (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844879/)
  • Yale News, "In search for Alzheimer’s drug, a major STEP forward", in Yale News, August, 6, 2014: (http://news.yale.edu/2014/08/06/search-alzheimer-s-drug-major-step-forward)
  • Johnson, M.A. and Lambroso P.J., "A common STEP in the synaptic pathology of diverse neuropsychiatric disorders", in Yale Journal of Biology and Medicine, December, 13, 2012: (http://www.ncbi.nlm.nih.gov/pubmed/23239949)
  • Baum M.L. and others, "A STEP forward in neural function and degeneration", in Communicative & Integrative Biology, September, 3, 2010: (http://www.ncbi.nlm.nih.gov/pubmed/21057629)
  • Kulikov A.V. and others, "A new synthetic varacin analogue, 8-(trifluoromethyl)-1,2,3,4,5- benzopentathiepin-6- amine hydrochloride (TC-2153), decreased hereditary catalepsy and increased the BDNF gene expression in the hippocampus in mice", in Psychopharmacology, June, 2012: (http://www.ncbi.nlm.nih.gov/pubmed/22127556)
  • Xu J. and others, "Inhibitor of the tyrosine phosphatase STEP reverses cognitive deficits in a mouse model of Alzheimer's disease", in PLoS Biology, August, 5, 2014: (http://www.ncbi.nlm.nih.gov/pubmed/25093460)
  • Zhang Y. and others, "Genetic reduction of striatal-enriched tyrosine phosphatase (STEP) reverses cognitive and cellular deficits in an Alzheimer's disease mouse model", in Proceedings of the National Academy of Sciences of the United States, November, 2, 2010: (http://www.ncbi.nlm.nih.gov/pubmed/20956308)